CUSIP: 62856X300
What is CUSIP 62856X300?
CUSIP 62856X300 identifies QCLS - Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 62856X300:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | 74% | $28,646,744 | 8,475,368 | PharmaCyte Biotech, Inc. | 14 Nov 2025 |
As of 31 Dec 2025, 18 institutional investors reported holding 752,721 shares of Q/C TECHNOLOGIES, INC. - Common Stock, par value $0.001 per share (QCLS). This represents 6.6% of the company’s total 11,453,200 outstanding shares.